BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 17521225)

  • 1. Effect of HMG-CoA reductase inhibitors on beta-amyloid peptide levels: implications for Alzheimer's disease.
    Höglund K; Blennow K
    CNS Drugs; 2007; 21(6):449-62. PubMed ID: 17521225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins: drugs for Alzheimer's disease?
    Eckert GP; Wood WG; Müller WE
    J Neural Transm (Vienna); 2005 Aug; 112(8):1057-71. PubMed ID: 15682268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol and Alzheimer's disease: is there a link?
    Simons M; Keller P; Dichgans J; Schulz JB
    Neurology; 2001 Sep; 57(6):1089-93. PubMed ID: 11571339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol and Alzheimer's disease: a still poorly understood correlation.
    Ricciarelli R; Canepa E; Marengo B; Marinari UM; Poli G; Pronzato MA; Domenicotti C
    IUBMB Life; 2012 Dec; 64(12):931-5. PubMed ID: 23124820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of statins on beta-amyloid metabolism in humans: potential importance for the development of senile plaques in Alzheimer's disease.
    Höglund K; Wallin A; Blennow K
    Acta Neurol Scand Suppl; 2006; 185():87-92. PubMed ID: 16866916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simvastatin and other HMG-CoA reductase inhibitors on brain cholesterol levels in Alzheimer's disease.
    Longenberger J; Shah ZA
    Curr Alzheimer Res; 2011 Jun; 8(4):434-42. PubMed ID: 21244355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can statins put the brakes on Alzheimer's disease?
    Whitfield JF
    Expert Opin Investig Drugs; 2006 Dec; 15(12):1479-85. PubMed ID: 17107274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin treatment and a disease-specific pattern of beta-amyloid peptides in Alzheimer's disease.
    Höglund K; Syversen S; Lewczuk P; Wallin A; Wiltfang J; Blennow K
    Exp Brain Res; 2005 Jul; 164(2):205-14. PubMed ID: 15937702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological concentrations of the HMG-CoA reductase inhibitor lovastatin decrease the formation of the Alzheimer beta-amyloid peptide in vitro and in patients.
    Buxbaum JD; Cullen EI; Friedhoff LT
    Front Biosci; 2002 Apr; 7():a50-9. PubMed ID: 11900994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cholesterol and Alzheimer's disease].
    Kálmán J; Janka Z
    Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin-like drugs for the treatment of brain cholesterol loss in Alzheimer's disease.
    Biondi E
    Curr Drug Saf; 2007 Sep; 2(3):173-6. PubMed ID: 18690964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of statins on Alzheimer's disease biomarkers in cerebrospinal fluid.
    Riekse RG; Li G; Petrie EC; Leverenz JB; Vavrek D; Vuletic S; Albers JJ; Montine TJ; Lee VM; Lee M; Seubert P; Galasko D; Schellenberg GD; Hazzard WR; Peskind ER
    J Alzheimers Dis; 2006 Dec; 10(4):399-406. PubMed ID: 17183151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol and statins in Alzheimer's disease: current controversies.
    Fonseca AC; Resende R; Oliveira CR; Pereira CM
    Exp Neurol; 2010 Jun; 223(2):282-93. PubMed ID: 19782682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin therapy for Alzheimer's disease: will it work?
    Petanceska SS; DeRosa S; Olm V; Diaz N; Sharma A; Thomas-Bryant T; Duff K; Pappolla M; Refolo LM
    J Mol Neurosci; 2002; 19(1-2):155-61. PubMed ID: 12212773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Link between heart disease, cholesterol, and Alzheimer's disease: a review.
    Sparks DL; Martin TA; Gross DR; Hunsaker JC
    Microsc Res Tech; 2000 Aug; 50(4):287-90. PubMed ID: 10936882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease, cholesterol, and statins: the junctions of important metabolic pathways.
    Silva T; Teixeira J; Remião F; Borges F
    Angew Chem Int Ed Engl; 2013 Jan; 52(4):1110-21. PubMed ID: 23280829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease-modifying therapies in Alzheimer's disease: how far have we come?
    Hüll M; Berger M; Heneka M
    Drugs; 2006; 66(16):2075-93. PubMed ID: 17112302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol and Alzheimer's disease.
    Wolozin B
    Biochem Soc Trans; 2002 Aug; 30(4):525-9. PubMed ID: 12196129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-assessing the relationship between cholesterol, statins and Alzheimer's disease.
    Wolozin B; Manger J; Bryant R; Cordy J; Green RC; McKee A
    Acta Neurol Scand Suppl; 2006; 185():63-70. PubMed ID: 16866913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging amyloid beta (Ab) peptide modulators for the treatment of Alzheimer's disease (AD).
    Lukiw WJ
    Expert Opin Emerg Drugs; 2008 Jun; 13(2):255-71. PubMed ID: 18537520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.